Loading
Disease Burden / Heart Failure · Journal article
Renal Failure · June 2, 2026
Reinforces what was already believed, rather than introducing something new.
This large retrospective study of 10,934 hyperkalemia episodes demonstrates that an EHR-integrated management system improved process measures (diagnosis, treatment, and review rates) and reduced hospitalization costs and length of stay in select comorbid subgroups. The findings support the value of system-level interventions to standardize hyperkalemia management in real-world settings.
Retrospective cohort study. Patients with hyperkalemia episodes, including subgroups with chronic kidney disease, heart failure, and diabetes mellitus comorbidities. Intervention: Hyperkalemia standardized group managed with 'Serum Potassium Management Center System' (EHR-integrated management system). Compared with: Hyperkalemia routine care group. n = 10,934.
Diagnosis rate was significantly higher in the standardized group (19.00% vs. 15.43%, p < 0.05) Treatment rate was significantly higher in the standardized group (85.23% vs. 58.29%, p < 0.05) Review rate was significantly higher in the standardized group (89.41% vs. 60.86%, p < 0.05)
No long-term clinical outcomes (e.g., mortality, cardiac events, recurrence) reported
The system-level intervention demonstrates feasibility and effectiveness in improving adherence to hyperkalemia management protocols, with measurable gains in process quality and resource utilization in complex comorbid patients. Clinicians and health systems may consider adopting similar EHR-integrated workflows to standardize care.
Large retrospective cohort comparing EHR-integrated system to routine care with improved process measures and reduced costs in select subgroups.
As stated by the source record.
Quoted from the source exactly as published.
The system-level intervention demonstrates feasibility and effectiveness in improving adherence to hyperkalemia management protocols, with measurable gains in process quality and resource utilization in complex comorbid patients. Clinicians and health systems may consider adopting similar EHR-integrated workflows to standardize care.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This retrospective study analyzed 10,934 hyperkalemia episodes to compare outcomes between the hyperkalemia routine group and the hyperkalemia standardized group, the latter managed with a strategy supported by the 'Serum Potassium Management Center System' in a real-world implementation setting. The study compared process and outcome metrics between this system-level intervention cohort and the routine care cohort. The hyperkalemia standardized group exhibited significantly higher rates of diagnosis (19.00% vs. 15.43%), treatment (85.23% vs. 58.29%), and review (89.41% vs. 60.86%) (all p < 0.05). With respect to disease burden, the hyperkalemia standardized group was associated with lower hospitalization costs in the chronic kidney disease-heart failure (CKD-HF) and chronic kidney disease-diabtes mellitus-heart failure comorbid subgroups, as well as shorter hospital stays in the CKD-HF comorbid subgroup (all p < 0.05). A non-significant trend toward reduced hospitalization costs and shorter hospital stays was also observed in the CKD subgroup. In conclusion, implementation of the 'Serum Potassium Management Center System' was associated with improved quality of hyperkalemia care, as reflected by more favorable process indicators and disease burden-related outcomes.This trial was registered with the Chinese Clinical Trial Registry (ChiCTR) ChiCTR2600116550 on January 12, 2026.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.